Journal Information
Full text access
Introducción
Visits
9999
José Luis Izquierdo Alonso
Servicio de Neumología, Hospital Universitario, Guadalajara, España
This item has received
Article information
Full text is only aviable in PDF
Bibliografía
[1.]
G. Peces-Barba, J.A. Barberà, A. Agustí, C. Casanova, A. Casas, J.L. Izquierdo.
Guía clínica SEPAR-ALAT de diagnóstico y tratamiento de la EPOC.
Arch Bronconeumol, 44 (2008), pp. 271-281
[2.]
J.L. Izquierdo.
The burden of COPD in Spain: Results from the confronting survey.
Respir Med, 97 (2003), pp. S61-S69
[3.]
P. Enright.
Does screening for COPD by primary care physicians have the potential to cause more harm than good?.
Chest, 129 (2006), pp. 833-834
[4.]
A. Punturieri, T.L. Croxton, G.G. Weinmann, J.P. Kiley.
Chronic obstructive pulmonary disease: A view from the NHLBI.
Am J Respir Crit Care Med, 178 (2008), pp. 441-443
[5.]
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of COPD. Disponible en: www.goldcopd.com
[6.]
M. Pistolesi, G. Camiciottoli, M. Paoletti, C. Marmai, F. Lavorini, E. Meoni, et al.
Identification of a predominant COPD phenotype in clinical practice.
Respir Med, 102 (2008), pp. 367-376
[7.]
P.J. Barnes.
New therapies for chronic obstructive pulmonary disease.
Med Princ Pract, 19 (2010), pp. 330-338
[8.]
A. Hatzelmann, E.J. Morcillo, G. Lungarella, S. Adnot, S. Sanjar, R. Beume, et al.
The preclinical pharmacology of roflumilast: A selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease.
Pulm Pharmacol Ther, 23 (2010), pp. 235-256
[9.]
P.M. Calverley, K.F. Rabe, U.M. Goehring, S. Kristiansen, L.M. Fabbri, F.J. Martínez.
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials.
Lancet, 374 (2009), pp. 685-694
[10.]
L.M. Fabbri, P. Calverley, J.L. Izquierdo, D. Bundschuh, M. Brose, F.J. Martínez, et al.
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials.
Lancet, 374 (2009), pp. 695-703
Copyright © 2010. Sociedad Española de Neumología y Cirugía Torácica